Yahoo · Sep 11, 2026
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.
NYSE · COR
Cencora, Inc.
Healthcare · Medical - Distribution
$323.29
Down-$2.94 (-0.90%)
Updated Sep 16, 2026, 10:56 AM
SID Score
5.6/10
Composite research score
Smart Money
59/100
Neutral
- Market cap
- 66.71B
- P/E ratio
- 42.94
- Dividend yield
- 0.70%
- 52-week range
- $244.82 – $376.92
- Volume
- 913.5K
- Avg. volume
- 1.54M
Price performance
COR price history
1M range · 20 trading sessions · Daily adjusted prices
COR closed at $323.29 after 20 trading sessions, up 2.26% for the selected period.
- Last close
- $323.29
- Period change
- +2.26%
- Period low
- $314.69
- Period high
- $337.22
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $324.98 | $325.875 | $318.08 | $323.29 | 913.5K |
| Sep 14, 2026 | $325.64 | $327.79 | $322.46 | $326.23 | 1.06M |
| Sep 11, 2026 | $323.99 | $325.125 | $317.96 | $321.57 | 844.06K |
| Sep 10, 2026 | $326.34 | $327.90 | $320.91 | $320.95 | 1.35M |
| Sep 9, 2026 | $322.24 | $326.99 | $321.915 | $323.32 | 1.22M |
| Sep 8, 2026 | $327.55 | $330.00 | $323.05 | $324.69 | 2.2M |
| Sep 4, 2026 | $333.48 | $336.01 | $330.201 | $330.95 | 1.03M |
| Sep 3, 2026 | $337.90 | $338.71 | $334.87 | $337.22 | 1.09M |
| Sep 2, 2026 | $330.62 | $337.91 | $330.62 | $336.36 | 1.4M |
| Sep 1, 2026 | $325.97 | $331.65 | $325.92 | $330.97 | 1.52M |
| Aug 31, 2026 | $321.11 | $326.57 | $319.04 | $323.60 | 1.39M |
| Aug 28, 2026 | $322.30 | $323.74 | $320.39 | $322.03 | 628.86K |
| Aug 27, 2026 | $324.35 | $324.68 | $320.465 | $321.23 | 1.07M |
| Aug 26, 2026 | $328.39 | $330.995 | $326.30 | $327.79 | 841.57K |
| Aug 25, 2026 | $322.68 | $328.51 | $321.43 | $328.06 | 1.11M |
| Aug 24, 2026 | $317.76 | $324.58 | $317.65 | $323.77 | 760.4K |
| Aug 21, 2026 | $314.74 | $320.2137 | $313.13 | $318.04 | 905.4K |
| Aug 20, 2026 | $314.77 | $318.23 | $312.605 | $314.69 | 1.18M |
| Aug 19, 2026 | $314.03 | $322.50 | $312.02 | $317.10 | 1.18M |
| Aug 18, 2026 | $315.99 | $320.00 | $313.92 | $316.13 | 1.03M |
Latest COR news
The latest Smart Investors Daily articles mentioning COR.
Stock researchCompany · Overview
COR research
Overview
Company profile and research snapshot.
Company profile
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $373.17
- Implied upside
- —
- Analysts
- 14
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 8, 2026 | RBC Capital | Sector Perform | — |
| Aug 19, 2026 | RBC Capital | Sector Perform | — |
| Aug 11, 2026 | Wells Fargo | Overweight | — |
| Aug 7, 2026 | JP Morgan | Overweight | — |
| Aug 7, 2026 | Morgan Stanley | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 9, 2026
Is Cencora Stock Underperforming the Dow?
Despite lagging behind the Dow over the past 12 months, Cencora continues to receive a highly bullish outlook from Wall Street analysts.
Yahoo · Sep 8, 2026
Q2 Earnings Outperformers: Cencora (NYSE:COR) And The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its peers.
SeekingAlpha · Sep 8, 2026
Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Cencora, Inc. (COR) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 9:30 AM EDTCompany ParticipantsRobert Mauch - President, CEO &...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
